Itpase gene polymorphisms associated with adverse drug reactions to azathioprine

• 1. 甲氨蝶呤药物不良反应相关基因多态性检测试剂盒及检测方法 [P] . 中国专利： CN109811053A . 2019-05-28
• 2. 与药物不良反应相关的HLA等位基因及其检测方法 [P] . 中国专利： CN101454462A . 2009-06-10
• 3. ITPase gene polymorphisms associated with adverse drug reactions to azathioprine therapy [P] . 美国专利： US7972780B2 . 2011-07-05

  机译： ITPase基因多态性与硫唑嘌呤治疗的药物不良反应相关

• 4. Itpase gene polymorphisms associated with adverse drug reactions to azathioprine [P] . 英国专利： GB2426584A . 2006-11-29

  机译： 与硫唑嘌呤药物不良反应相关的Itpase基因多态性

• 5. ITPASE GENE POLYMORPHISMS ASSOCIATED WITH ADVERSE DRUG REACTIONS TO AZATHIOPRINE THERAPY [P] . 世界知识产权组织专利： WO2005078125A3 . 2005-12-01

  机译： ITPase基因多态性与不良药物反应相关的氮唑嘌呤治疗

• 1. Prevalence of Adverse Drug Reactions to Second Line Anti Tuberculosis Drugs in Nigeria: A Cross-Sectional Study [J] . Abideen Adedayo Ganiyu, Yohanna Kambai Avong, Akinwumi Akinyede, 结核病研究（英文） . 2021,第002期
• 2. Discovery of the relations between genetic polymorphism and adverse drug reactions [C] . Liang Zhaohui, Zhang Gang, Huang Jimmy Xiangji IEEE International Conference on Bioinformatics and Biomedicine . 2015
• 3. Involvement of Th17 Pathway in Adverse Drug Reactions: Mechanistic Investigation of Drug-Induced Autoimmunity and Drug-induced Liver Injury. [D] . Zhu, Ervin Xu. 2012
• 4. The Association Between Azathioprine Genetic Polymorphisms Clinical Efficacy and Adverse Drug Reactions Among Egyptian Patients with Autoimmune Diseases [O] . Nermeen Abuelsoud, Hala Fayed, Engy Elkateeb 2021
• 5. The Association Between Azathioprine Genetic Polymorphisms, Clinical Efficacy and Adverse Drug Reactions Among Egyptian Patients with Autoimmune Diseases [O] . Nermeen Abuelsoud, Hala Fayed, Engy Elkateeb 2021

• 1. Adverse Drug Reactions in Patients on Second Line Anti-Tubercular Drugs for Drug Resistant Tuberculosis in Rural Tertiary Care Hospital in North India [J] . Anita Kumari ,Parveen Kumar Sharma ,Dinesh Kansal . 结核病研究（英文） . 2018,第3期
• 2. Adverse Drug Reactions in Management of Multi Drug Resistant Tuberculosis, in Tertiary Chest Institute [J] . J. S. Akshata ,Anushree Chakrabarthy ,R. Swapna . 结核病研究（英文） . 2015,第2期
• 3. Adverse reactions of HMG—CoA reductase inhibitors as a consequence of drug—drug interaction [J] . IkedaT . 中国药理学与毒理学杂志 . 2002,第006期
• 4. Mining potential adverse drug reactions of Houttuynia cordata Thunb from "real world" cases [J] . Wei-Xiu Fan12 ,Li-Ting Yu12 ,Li-Ping Yang2 . TMR食疗与健康管理 . 2019,第003期
• 5. IMPDH基因多态性的测定及其与硫唑嘌呤所致不良反应的相关性研究 [C] . 李维亮 ,辛华雯 ,李元启 . 2013中国药学大会暨第十三届中国药师周 . 2013
• 6. 肾移植受者IMPDH和HGPRT活性及基因多态性与硫唑嘌呤所致不良反应的相关性研究 [A] . 马晓琴 . 2013